Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
Research ArticlePractice

Treating constipation during pregnancy

Magan Trottier, Aida Erebara and Pina Bozzo
Canadian Family Physician August 2012, 58 (8) 836-838;
Magan Trottier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aida Erebara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pina Bozzo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

Question Many of my patients experience constipation during pregnancy, even after increasing dietary fibre and fluids. Are there any safe treatments I can recommend to them?

Answer Although the recommended first-line therapy for constipation includes increasing fibre, fluids, and exercise, these are sometimes ineffective. Therefore, laxatives such as bulk-forming agents, lubricant laxatives, stool softeners, osmotic laxatives, and stimulant laxatives might be considered. Although few of the various types of laxatives have been assessed for safety in pregnancy, they have minimal systemic absorption. Therefore, they are not expected to be associated with an increased risk of congenital anomalies. However, it is recommended that osmotic and stimulant laxatives be used only in the short term or occasionally to avoid dehydration or electrolyte imbalances in pregnant women.

It has been estimated that approximately 11% to 38% of pregnant women experience constipation,1 which is generally described as infrequent bowel movements or difficult evacuation.2 Pregnancy predisposes women to developing constipation owing to physiologic and anatomic changes in the gastrointestinal tract. For instance, rising progesterone levels during pregnancy and reduced motilin hormone levels lead to increases in bowel transit time.2,3 Also, there is increased water absorption from the intestines, which causes stool to dry out. Decreased maternal activity and increased vitamin supplementation (eg, iron and calcium) can further contribute to constipation.3 Later in pregnancy, an enlarging uterus might slow onward movement of feces.4 Constipation can result in serious complications such as fecal impaction, but such complications are rare. It is important to note that constipation negatively affects patients’ daily lives and is second only to nausea as the most common gastrointestinal complaint in pregnancy.2,4

Treatment

Many patients find relief from constipation with an increase in dietary fibre and fluids, as well as daily exercise. Probiotics that alter the colonic flora might also improve bowel function.3 If these are ineffective, laxatives are the second line of therapy (Table 1).2,5,6 In general, there are insufficient data on the use of laxatives in pregnancy; however, limited studies have been performed for specific laxatives, and the safety of others can be inferred from information about their systemic absorption (Table 2).7–16

View this table:
  • View inline
  • View popup
Table 1

Types of laxatives

View this table:
  • View inline
  • View popup
Table 2

Studies examining safety in pregnancy and systemic absorption of commonly used laxatives

Bulk-forming agents

Bulk-forming agents are not absorbed4 or associated with increased risk of malformations7; therefore, they are considered safe for long-term use during pregnancy. However, they are not always effective and might be associated with unpleasant side effects such as gas, bloating, and cramping.4

Stool softeners

Docusate sodium has not been associated with adverse effects in pregnancy in a number of studies, and it is thus also considered safe to use.7–10 There is one case report of maternal chronic use of docusate sodium throughout pregnancy, which was associated with symptomatic hypomagnesemia in the neonate.17

Lubricant laxatives

Mineral oil is poorly absorbed from the gastrointestinal tract18 and does not appear to be associated with adverse effects.19 There is controversy about whether prolonged use reduces the absorption of fat-soluble vitamins, although this appears to be a theoretical rather than actual risk.20

Osmotic laxatives

Lactulose and polyethylene glycol are poorly absorbed systemically.11,12 Their use has not been associated with adverse effects; however, individuals might experience side effects such as flatulence and bloating.3 Theoretically, prolonged use of osmotic laxatives might lead to electrolyte imbalances.3

Stimulant laxatives

Absorption of bisacodyl is minimal as it has poor bioavailability.13,14 Senna does not appear to be associated with increased risk of malformations15 and is not readily absorbed systemically.16 However, women might experience unpleasant side effects such as abdominal cramps with the use of stimulant laxatives.2 Similar to osmotic laxatives, prolonged use might theoretically lead to electrolyte imbalances.3

Conclusion

The first line of therapy for constipation includes increasing dietary fibre and water intake and moderate amounts of daily exercise.3 If these are ineffective, laxatives are the second line of therapy. Because most laxatives are not absorbed systemically, short-term use has not been, and is not expected to be, associated with an increased risk of malformations. However, as with the general population, it is recommended that osmotic and stimulant laxatives be used only in the short term or occasionally to avoid dehydration or electrolyte imbalances and the theoretical risk of “cathartic colon.”21

Notes

MOTHERISK

Motherisk questions are prepared by the Motherisk Team at the Hospital for Sick Children in Toronto, Ont. Ms Trottier and Dr Erebara are counselors and Ms Bozzo is Assistant Director of the Motherisk Program.

Do you have questions about the effects of drugs, chemicals, radiation, or infections in women who are pregnant or breastfeeding? We invite you to submit them to the Motherisk Program by fax at 416 813–7562; they will be addressed in future Motherisk Updates.

Published Motherisk Updates are available on the Canadian Family Physician website (www.cfp.ca) and also on the Motherisk website (www.motherisk.org).

Footnotes

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. ↵
    1. Jewell DJ,
    2. Young G
    . Interventions for treating constipation in pregnancy. Cochrane Database Syst Rev 2001;(2):CD001142.
  2. ↵
    1. West L,
    2. Warren J,
    3. Cutts T
    . Diagnosis and management of irritable bowel syndrome, constipation, and diarrhea in pregnancy. Gastroenterol Clin North Am 1992;21(4):793-802.
    OpenUrlPubMed
  3. ↵
    1. Longo SA,
    2. Moore RC,
    3. Canzoneri BJ,
    4. Robichaux A
    . Gastrointestinal conditions during pregnancy. Clin Colon Rectal Surg 2010;23(2):80-9.
    OpenUrlPubMed
  4. ↵
    1. Cullen G,
    2. O’Donoghue D
    . Constipation and pregnancy. Best Pract Res Clin Gastroenterol 2007;21(5):807-18.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Tack J,
    2. Müller-Lissner S,
    3. Stanghellini V,
    4. Boeckxstaens G,
    5. Kamm MA,
    6. Simren M,
    7. et al
    . Diagnosis and treatment of chronic constipation—a European perspective. Neurogastroenterol Motil 2011;23(8):697-710. Epub 2011 May 24.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Moriarty KJ,
    2. Kelly MJ,
    3. Beetham R,
    4. Clark ML
    . Studies on the mechanism of action of dioctyl sodium sulphosuccinate in the human jejunum. Gut 1985;26(10):1008-13.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Jick H,
    2. Holmes LB,
    3. Hunter JR,
    4. Madsen S,
    5. Stergachis A
    . First-trimester drug use and congenital disorders. JAMA 1981;246(4):343-6.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Heinonen OP,
    2. Slone D,
    3. Shapiro S
    . Birth defects and drugs in pregnancy: maternal drug exposure and congenital malformations. Littleton, MA: Publishing Sciences Group; 1977. p. 442.
  9. ↵
    1. Aselton P,
    2. Jick H,
    3. Milunsky A,
    4. Hunter JR,
    5. Stergachis A
    . First-trimester drug use and congenital disorders. Obstet Gynecol 1985;65(4):451-5.
    OpenUrlPubMed
  10. ↵
    1. Briggs GG,
    2. Freeman RK,
    3. Yaffe SJ
    . Drugs in pregnancy and lactation. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011. p. 439.
  11. ↵
    1. Carulli N,
    2. Salvioli GF,
    3. Manenti F
    . Absorption of lactulose in man. Digestion 1972;6(3):139-45.
    OpenUrlPubMed
  12. ↵
    1. Wilkinson R
    . Polyethylene glycol 4000 as a continuously administered nonabsorbable faecal marker for metabolic balance studies in human subjects. Gut 1971;12(8):654-60.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Roth W,
    2. Beschke K
    . Pharmacokinetics and laxative effect of bisacodyl following administration of various dosage forms [article in German]. Arzneimittelforschung 1988;38(4):570-4.
    OpenUrlPubMed
  14. ↵
    1. Flig E,
    2. Hermann TW,
    3. Zabel M
    . Is bisacodyl absorbed at all from suppositories in man? Int J Pharm 2000;196(1):11-20.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Acs N,
    2. Bánhidy F,
    3. Puhó EH,
    4. Czeizel AE
    . Senna treatment in pregnant women and congenital abnormalities in their offspring—a population-based case-control study. Reprod Toxicol 2009;28(1):100-4. Epub 2009 Feb 24.
    OpenUrlPubMed
  16. ↵
    1. Krumbiegel G,
    2. Schulz HU
    . Rhein and aloe-emodin kinetics from senna laxatives in man. Pharmacology 1993;47(Suppl 1):120-4.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Schindler AM
    . Isolated neonatal hypomagnesaemia associated with maternal overuse of stool softener. Lancet 1984;2(8406):822.
    OpenUrlPubMed
  18. ↵
    1. Hazardous Substances Data Bank [website]
    . Mineral oil. CASRN: 8012-95-1. Bethedsa, MD: U.S. National Library of Medicine; 2005. Available from: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed 2012 Jun 26.
  19. ↵
    1. Sharif F,
    2. Crushell E,
    3. O’Driscoll K,
    4. Bourke B
    . Liquid paraffin: a reappraisal of its role in the treatment of constipation. Arch Dis Child 2001;85(2):121-4.
    OpenUrlFREE Full Text
  20. ↵
    1. Gal-Ezer S,
    2. Shaoul R
    . The safety of mineral oil in the treatment of constipation—a lesson from prolonged overdose. Clin Pediatr (Phila) 2006;45(9):856-8.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Joo JS,
    2. Ehrenpreis ED,
    3. Gonzalez L,
    4. Kaye M,
    5. Breno B,
    6. Wexner SD,
    7. et al
    . Alterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon revisited. J Clin Gastroenterol 1998;26(4):283-6.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 58 (8)
Canadian Family Physician
Vol. 58, Issue 8
1 Aug 2012
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Treating constipation during pregnancy
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Treating constipation during pregnancy
Magan Trottier, Aida Erebara, Pina Bozzo
Canadian Family Physician Aug 2012, 58 (8) 836-838;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Treating constipation during pregnancy
Magan Trottier, Aida Erebara, Pina Bozzo
Canadian Family Physician Aug 2012, 58 (8) 836-838;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Treatment
    • Conclusion
    • Notes
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Ischaemic colitis diagnosed by sigmoidoscopy during pregnancy
  • Google Scholar

More in this TOC Section

Practice

  • Is 45 the new 50 in colorectal cancer screening?
  • Approach to diagnosis and management of childhood attention deficit hyperactivity disorder
  • Determining if and how older patients can safely stay at home with additional services
Show more Practice

Motherisk Update

  • Hepatitis A infection during pregnancy
  • Fluconazole use during breastfeeding
  • Is it safe to breastfeed while taking methylphenidate?
Show more Motherisk Update

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2023 by The College of Family Physicians of Canada

Powered by HighWire